Diabetes
Research from University of Texas, Division of Endocrinology yields new findings on diabetes
Published in Drug Week, December 31st, 2010
2010 DEC 31 -- A report, 'Incorporating incretin-based therapies into clinical practice: differences between glucagon-like Peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors,' is newly published data in Mayo Clinic Proceedings Mayo Clinic. "Type 2 diabetes mellitus (DM) is a prevalent disorder that affects children, adolescents, and adults worldwide. In addition to risks of microvascular disease, patients with type 2 DM often have multiple risk factors of macrovascular disease; for example, approximately 90% of patients with type 2 DM are overweight/obese," scientists in the United States report.
"Type 2 DM is a complex disease that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-12-31)
More Articles from Drug Week
- Metalloporphyrins
Wonkwang University, Research Center reports research in metalloporphyrins - Alzheimer Disease
Unraveling Alzheimer's: Simple small molecules could untangle complex disease - Proteomics
University of Wisconsin-Madison, Department of Nutritional Sciences details research in proteomics - Stem Cell Research
University of Wisconsin-Madison publishes research in stem cell research - Bioelectronics
University of Twente, Institute of Nanotechnology publishes research in bioelectronics - Schizophrenia
University of Pittsburgh reports research in schizophrenia - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
